Tiny and traceable man-made crystals, known as quantum dots, may be useful in carrying toxins to select cells in the brain, allowing researchers to better understand Parkinsons neurodegenerative processes by being able to model and visualize them, researchers in Canada report. Their study, Quantum dot conjugated saporin activates microglia and induces selective substantia nigra degeneration, was published in NeuroToxicology Continue reading →

Global Parkinsons Disease Treatments Market 2019 2026 Report gives an overview of the related market involving types, applications and key manufacturers with characteristics, technology and market chain with analysis and recent market trends and development. The report has opinions from industry experts and offers an outline of the past years and the current market situation. Continue reading →

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (Newron) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced today that the U.S. Food and Drug Administration (FDA) has granted the Rare Pediatric Disease designation for sarizotan, the companys product candidate for the treatment of Rett syndrome, a rare neurodevelopmental disorder primarily affecting females, with no approved treatments currently available. Continue reading →